The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for NovApproach Spine sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
NovApproach Spine is a medical equipment company that designs, develops, and manufactures medical devices for spinal surgery. Its SupineATP technology is used to realign the spine in complex lumbar interbody fusion cases, including those involving multiple levels. Its OneLIF Interbody Fusion System works in harmony with SupineATP, enhancing its capabilities. The company partners with spine and spinal access surgeons to create innovative approaches and implants aimed at simplifying spine surgery. NovApproach is headquartered in Alachua, Florida, the US.
The key metrics of NovApproach Spine related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As NovApproach Spine is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as NovApproach Spine.
For a detailed understanding of the performance of NovApproach Spine, buy the report here.